About me
Kim Quaintance-Lunn is Vice President, Head of Regulatory Science & Execution, for Alexion Pharmaceuticals; Strategic Advisor to the DIA Board of Directors; and Director at Large and Treasurer for the FDA Alumni Association. At Alexion, Kim is responsible for leading and implementing the regulatory strategies for US and EU for all Alexion programs and Regulatory Policy and Intelligence. Kim joined Alexion in June 2024. Prior to joining Alexion, Kim served in multiple roles in Regulatory Affairs and was a Distinguished Science Fellow at Bayer; Senior Director, Global Regulatory Policy & Intelligence at Eisai; and Associate Director for Regulatory Affairs in CDER’s Office of New Drugs. Kim began her career as a research scientist at Pfizer.
